Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Journal of Clinical Gastroenterology|June 29, 2012
Peginterferon-α-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantationFredric D Gordon, Paul Kwo, Reem Ghalib, et al.Journal of Hepatology|December 16, 2020
Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortalityMohamed A Abdallah, Yong-Fang Kuo, Sumeet Asrani, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 13, 2016
Short-duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study)Mark S Sulkowski, Steve Flamm, Zeid Kayali, et al.Hepatology Communications|April 6, 2018
Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohortPaul Kwo, Michael W Fried, K Rajender Reddy, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2004
Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipientsA Joseph Tector, Jonathan A Fridell, Richard S Mangus, et al.Hepatology (Baltimore, Md.)|October 24, 2002
A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis CA Obaid Shakil, Brendon McGuire, Jeff Crippin, et al.Research Square|June 5, 2026
Ahead, a Novel Validated Machine Learning Model for Clinical Diagnosis of Alcohol Associated HepatitisDavid Malicote, Gene Im, Ethan Weinberg, et al.Journal of Gastroenterology|March 15, 2019
Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infectionAtsushi Naganuma, Kazuaki Chayama, Kazuo Notsumata, et al.Gastroenterology|October 14, 2008
A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitisNicholas C Boetticher, Craig J Peine, Paul Kwo, et al.Hepatology (Baltimore, Md.)|September 8, 2021
Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver diseaseAshwani K Singal, Paul Kwo, Allison Kwong, et al.Pageof 7